As of 2025-06-20, the Relative Valuation of Acacia Pharma Group PLC (ACPH.BR) is (11.85) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.89 EUR, the upside of Acacia Pharma Group PLC based on Relative Valuation is -1434.0%.
The range of the Relative Valuation is (12.84) - (12.28) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 14.1x | 11.6x |
| Forward P/E multiples | 14.7x - 17.2x | 15.6x |
| Fair Price | (12.84) - (12.28) | (11.85) |
| Upside | -1545.9% - -1483.1% | -1434.0% |
| Date | P/E |